TNGX vs. RVMDW
TNGX (Tango Therapeutics, Inc.) and RVMDW (Revolution Medicines Inc. Warrant) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past year, TNGX returned 433.65% vs 3027.90% for RVMDW. At a 0.10 correlation, their price movements are largely independent.
Performance
TNGX vs. RVMDW - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TNGX achieves a 220.43% return, which is significantly lower than RVMDW's 688.38% return.
TNGX
- 1D
- -0.39%
- 1M
- 40.27%
- YTD
- 220.43%
- 6M
- 232.83%
- 1Y
- 433.65%
- 3Y*
- 96.53%
- 5Y*
- 20.02%
- 10Y*
- —
RVMDW
- 1D
- 4.07%
- 1M
- 26.88%
- YTD
- 688.38%
- 6M
- 680.00%
- 1Y
- 3,027.90%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TNGX vs. RVMDW - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
TNGX Tango Therapeutics, Inc. | 220.43% | 186.73% | -68.79% | 31.82% |
RVMDW Revolution Medicines Inc. Warrant | 688.38% | 422.17% | -45.45% | -67.00% |
Correlation
The correlation between TNGX and RVMDW is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Nov 17, 2023 | 0.10 |
The correlation between TNGX and RVMDW shifts across timeframes, from 0.10 (all time) to 0.22 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
TNGX:
$4.08B
RVMDW:
$1.47B
TNGX:
-$0.89
RVMDW:
-$7.17
TNGX:
10.41
RVMDW:
0.98
TNGX:
$56.99M
RVMDW:
$0.00
TNGX:
$55.33M
RVMDW:
-$4.70M
TNGX:
-$111.92M
RVMDW:
-$1.34B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TNGX vs. RVMDW — Risk / Return Rank
TNGX
RVMDW
TNGX vs. RVMDW - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tango Therapeutics, Inc. (TNGX) and Revolution Medicines Inc. Warrant (RVMDW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TNGX | RVMDW | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -8.61 | ||
| Sortino ratioReturn per unit of downside risk | -1.59 | ||
| Omega ratioGain probability vs. loss probability | 1.55 | 1.76 | -0.21 |
| Calmar ratioReturn relative to maximum drawdown | 14.95 | 51.49 | -36.53 |
| Martin ratioReturn relative to average drawdown | 38.53 | 112.99 | -74.45 |
Loading charts...
Drawdowns
TNGX vs. RVMDW - Drawdown Comparison
The maximum TNGX drawdown since its inception was -93.64%, roughly equal to the maximum RVMDW drawdown of -96.90%. Use the drawdown chart below to compare losses from any high point for TNGX and RVMDW.
Loading charts...
Drawdown Indicators
| TNGX | RVMDW | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.64% | -96.90% | +3.26% |
Max Drawdown (1Y)Largest decline over 1 year | -29.24% | -59.65% | +30.41% |
Max Drawdown (3Y)Largest decline over 3 years | -91.46% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -93.64% | — | — |
Current DrawdownCurrent decline from peak | -13.71% | 0.00% | -13.71% |
Average DrawdownAverage peak-to-trough decline | -47.81% | -66.06% | +18.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.32% | 27.13% | -15.81% |
Volatility
TNGX vs. RVMDW - Volatility Comparison
Tango Therapeutics, Inc. (TNGX) has a higher volatility of 50.81% compared to Revolution Medicines Inc. Warrant (RVMDW) at 33.80%. This indicates that TNGX's price experiences larger fluctuations and is considered to be riskier than RVMDW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TNGX | RVMDW | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 50.81% | 33.80% | +17.01% |
Volatility (6M)Calculated over the trailing 6-month period | 79.15% | 149.62% | -70.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 100.42% | 237.26% | -136.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 102.22% | 311.22% | -209.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 96.03% | 311.22% | -215.19% |
Dividends
TNGX vs. RVMDW - Dividend Comparison
Neither TNGX nor RVMDW has paid dividends to shareholders.
Financials
TNGX vs. RVMDW - Financials Comparison
This section allows you to compare key financial metrics between Tango Therapeutics, Inc. and Revolution Medicines Inc. Warrant. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
TNGX and RVMDW have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TNGX has higher volatility (50.81%) compared to RVMDW (33.80%). In terms of maximum drawdown, TNGX dropped -93.64% vs RVMDW's -96.90%.
RVMDW currently has the higher Sharpe Ratio (12.97 vs 4.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TNGX and RVMDW
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer